
Allied to the focus of its sister company, Newport Pharmaceuticals Limited, KoRa Healthcare is involved in marketing products for the treatment of infectious disease, specifically sexually transmitted infections such as condylomata acuminata (genital warts).
Condyline® is indicated for the topical treatment of condylomata acuminata (warts) affecting the penis or female genitalia.